You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemin

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-ERCP Acute Pancreatitis Trial in Belgium, Taiwan (Hemin, )

Completed
  • Post-ERCP Acute Pancreatitis
  • Hemin
  • placebo
  • Brussels, Belgium
  • +5 more
Jul 5, 2021

Acute Intermittent Porphyria, Hereditary Coproporphyria, Variegate Porphyria Trial in Galveston (Hemin for injection, Placebo)

Recruiting
  • Acute Intermittent Porphyria
  • +2 more
  • Hemin for injection
  • Placebo
  • Galveston, Texas
    University of Texas Medical Branch
Nov 23, 2021

Acute Porphyria Biomarkers for Disease Activity

Active, not recruiting
  • Acute Intermittent Porphyria
  • +2 more
  • Hemin
  • Galveston, Texas
    University of Texas Medical Branch
Jul 27, 2021

Acute Porphyrias Trial in Galveston (Panhematin, Glucose)

Active, not recruiting
  • Acute Porphyrias
  • Panhematin
  • Glucose
  • Galveston, Texas
    University of Texas Medical Branch
Jul 27, 2021

Patients With Acute Hepatic Porphyria (AHP)

Recruiting
  • Acute Hepatic Porphyria
    • Birmingham, Alabama
    • +21 more
    Aug 11, 2022

    Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent Trial in Worldwide (Givosiran, Placebo)

    Completed
    Has Results
    • Acute Hepatic Porphyria
    • +6 more
    • Little Rock, Arkansas
    • +35 more
    May 31, 2022

    Periodontal Diseases Trial in Tanta (Frankincense Extract)

    Completed
    • Periodontal Diseases
    • Frankincense Extract
    • Tanta, Egypt
      Malak Mohamed Shoukheba
    Jul 16, 2021

    SARS-CoV 2, COVID-19 Trial in Manama (5-ALA-Phosphate + SFC (5-ALA + SFC))

    Completed
    • SARS-CoV 2
    • COVID-19
    • 5-ALA-Phosphate + SFC (5-ALA + SFC)
    • Manama, Bahrain
    • +1 more
    Feb 8, 2022

    SARS-COV 2, Covid19 Trial (5-ALA-Phosphate + SFC (5-ALA+SFC))

    Withdrawn
    • SARS-COV 2
    • Covid19
    • 5-ALA-Phosphate + SFC (5-ALA+SFC)
    • (no location specified)
    Sep 15, 2021

    Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of

    Recruiting
    • Intracerebral Hemorrhage
    • +4 more
    • Fingolimod 0.5 mg
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    Nov 28, 2022

    Dental Caries Extending Into Dentin Trial in Cairo (TheraCal, light-cured calcium hydroxide)

    Unknown status
    • Dental Caries Extending Into Dentin
    • Cairo, New Cairo, Egypt
      Hanaa Mohamed Morsy Mohamed
    Jul 31, 2018

    Gastroparesis, Diabetes Trial in Rochester (Hemin, Albumin)

    Completed
    Has Results
    • Gastroparesis
    • Diabetes Mellitus
    • Hemin
    • Albumin
    • Rochester, Minnesota
      Mayo Clinic
    Jan 5, 2016

    Cervical Carcinoma Trial in Nanning (Endostar, DDP)

    Unknown status
    • Cervical Carcinoma
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Mar 16, 2017

    Graft Failure, Ischemia-reperfusion Injury Trial in Edinburgh (Heme arginate (Normosang), 0.9% sodium chloride)

    Completed
    • Graft Failure
    • Ischemia-reperfusion Injury
    • Heme arginate (Normosang)
    • 0.9% sodium chloride
    • Edinburgh, Lothian, United Kingdom
      Royal Infirmary of Edinburgh/ University of Edinburgh
    May 26, 2015

    Chronic Periodontitis Trial (AmF/SnF2, mHA)

    Completed
    • Chronic Periodontitis
    • AmF/SnF2
    • mHA
    • (no location specified)
    Feb 26, 2016

    Gastroparesis Trial in Rochester (Nizatidine, Lisinopril, Placebo)

    Completed
    • Gastroparesis
    • Rochester, Minnesota
    • +1 more
    Apr 28, 2015

    Myelodysplastic Syndrome Trial in Chicago (Panhematin)

    Terminated
    Has Results
    • Myelodysplastic Syndrome
    • Chicago, Illinois
      Rush University Medical Center
    Oct 23, 2014

    Acute Intermittent Porphyria Trial in Pamplona, Madrid (rAAV2/5-PBGD vector dosage 1, rAAV2/5-PBGD vector dosage 2, rAAV2/5-PBGD

    Completed
    • Acute Intermittent Porphyria
    • rAAV2/5-PBGD vector dosage 1
    • +3 more
    • Pamplona, Navarra, Spain
    • +1 more
    Dec 17, 2014

    Observational Study of Acute Intermittent Porphyria Patients

    Completed
    • Acute Intermittent Porphyria
      • Pamplona, Navarra, Spain
      • +1 more
      Mar 11, 2014

      Healthy Volunteers Trial in Rochester (Hemin infusion, infusion)

      Completed
      • Healthy Volunteers
      • Hemin infusion
      • placebo infusion
      • Rochester, Minnesota
        Mayo Clinic
      Apr 16, 2009